02 Feb 2023

Atlantic clinical trial network gets $2.5-million boost from national research institute

Halifax, NS – Clinical trials are an important tool in finding new treatments and cures for patients. Nova Scotia Health officials reported that the Atlantic Clinical Trials Network (ACTN) was awarded up to $2.5 million from the Canadian Institutes of Health Research via its participation to CTTP (Clinical Trials Training Programs)-CANTRAIN.

19 Jan 2023

Government of Canada announces new clinical trials consortium, training platforms, and research projects to improve the health of Canadians

Clinical trials allow researchers to assess the safety and effectiveness of new drugs, treatments, and therapies for our population. It is through these studies and their collaborative networks, that medical innovation in Canada continues to evolve.

19 Jan 2023

Reinforcing Canada’s clinical trials infrastructure, training, and research

Clinical trials are an essential part of the healthcare sector and a crucial component of medical research and innovation. Clinical trials allow researchers to assess if new drugs, treatments, and therapies are safe and effective for the population.

19 Jan 2023

Significant funding to maximize access and drive excellence in clinical trials in Quebec and Canada

RI-MUHC researchers will lead or co-lead multiple projects awarded a total of $55 million from the Canadian Institutes of Health Research

19 Jan 2023

Canadian Consortium of Clinical Trials Training receives CIHR Funding

Halifax, NS – The Atlantic Clinical Trials Network (ACTN) will receive approximately $2.5 million for the creation of various student training opportunities at the masters, PhD, postdoctoral and postdoctoral fellow levels, along with the creation of six new positions in Atlantic Canada focused on the development and coordination of clinical trial professional training within the region.